Ganesan Vaidyanathan

4.8k total citations
128 papers, 3.9k citations indexed

About

Ganesan Vaidyanathan is a scholar working on Radiology, Nuclear Medicine and Imaging, Oncology and Neurology. According to data from OpenAlex, Ganesan Vaidyanathan has authored 128 papers receiving a total of 3.9k indexed citations (citations by other indexed papers that have themselves been cited), including 103 papers in Radiology, Nuclear Medicine and Imaging, 36 papers in Oncology and 33 papers in Neurology. Recurrent topics in Ganesan Vaidyanathan's work include Radiopharmaceutical Chemistry and Applications (89 papers), Medical Imaging Techniques and Applications (43 papers) and Neuroblastoma Research and Treatments (33 papers). Ganesan Vaidyanathan is often cited by papers focused on Radiopharmaceutical Chemistry and Applications (89 papers), Medical Imaging Techniques and Applications (43 papers) and Neuroblastoma Research and Treatments (33 papers). Ganesan Vaidyanathan collaborates with scholars based in United States, Belgium and United Kingdom. Ganesan Vaidyanathan's co-authors include Michael R. Zalutsky, Donna J. Affleck, Eftychia Koumarianou, Darell D. Bigner, Jae‐Yeon Choi, Zhengyuan Zhou, Nick Devoogdt, Darryl McDougald, Xiaoguang Zhao and Marek Pruszyński and has published in prestigious journals such as Cancer Research, Scientific Reports and Clinical Cancer Research.

In The Last Decade

Ganesan Vaidyanathan

126 papers receiving 3.9k citations

Peers

Ganesan Vaidyanathan
Reingard Senekowitsch–Schmidtke Germany
Hanwen Zhang United States
Jörgen Carlsson Sweden
Joseph A. O’Donoghue United States
Katherine A. Vallis United Kingdom
Chang H. Paik United States
Sean Carlin United States
Carmen Wängler Germany
Chien‐Hsing Chang United States
Margret Schottelius Germany
Reingard Senekowitsch–Schmidtke Germany
Ganesan Vaidyanathan
Citations per year, relative to Ganesan Vaidyanathan Ganesan Vaidyanathan (= 1×) peers Reingard Senekowitsch–Schmidtke

Countries citing papers authored by Ganesan Vaidyanathan

Since Specialization
Citations

This map shows the geographic impact of Ganesan Vaidyanathan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ganesan Vaidyanathan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ganesan Vaidyanathan more than expected).

Fields of papers citing papers by Ganesan Vaidyanathan

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Ganesan Vaidyanathan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ganesan Vaidyanathan. The network helps show where Ganesan Vaidyanathan may publish in the future.

Co-authorship network of co-authors of Ganesan Vaidyanathan

This figure shows the co-authorship network connecting the top 25 collaborators of Ganesan Vaidyanathan. A scholar is included among the top collaborators of Ganesan Vaidyanathan based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Ganesan Vaidyanathan. Ganesan Vaidyanathan is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Huynh, Truc T., et al.. (2025). Enhancing the therapeutic index of [211At]YF2 with iodo pseudo carrier: A simple strategy for reducing accumulation in kidneys, salivary and lacrimal glands. Nuclear Medicine and Biology. 146-147. 109028–109028. 1 indexed citations
2.
Batra, Vandana, Minu Samanta, Mehran Makvandi, et al.. (2022). Preclinical Development of [211At]meta- astatobenzylguanidine ([211At]MABG) as an Alpha Particle Radiopharmaceutical Therapy for Neuroblastoma. Clinical Cancer Research. 28(18). 4146–4157. 18 indexed citations
3.
Procissi, Daniele, Stephen A. Jannetti, Μαρκέλλα Ζαννίκου, et al.. (2022). Low-level whole-brain radiation enhances theranostic potential of single-domain antibody fragments for human epidermal growth factor receptor type 2 (HER2)-positive brain metastases. Neuro-Oncology Advances. 4(1). vdac135–vdac135. 1 indexed citations
4.
Feng, Yutian, et al.. (2022). Site-Specific Radiohalogenation of a HER2-Targeted Single-Domain Antibody Fragment Using a Novel Residualizing Prosthetic Agent. Journal of Medicinal Chemistry. 65(22). 15358–15373. 17 indexed citations
5.
Vaidyanathan, Ganesan, Oscar R. Pozzi, Jae‐Yeon Choi, et al.. (2020). Labeling Monoclonal Antibody with α-emitting 211 At at High Activity Levels via a Tin Precursor. Cancer Biotherapy and Radiopharmaceuticals. 35(7). 511–519. 9 indexed citations
6.
Liu, Yang, Austin B. Carpenter, Christopher J. Pirozzi, et al.. (2019). Non-invasive sensitive brain tumor detection using dual-modality bioimaging nanoprobe. Nanotechnology. 30(27). 275101–275101. 19 indexed citations
7.
Zhou, Zhengyuan, Nick Devoogdt, Michael R. Zalutsky, & Ganesan Vaidyanathan. (2018). An Efficient Method for Labeling Single Domain Antibody Fragments with 18F Using Tetrazine-Trans-Cyclooctene Ligation and a Renal Brush Border Enzyme-Cleavable Linker. Bioconjugate Chemistry. 29(12). 4090–4103. 40 indexed citations
8.
Zhou, Zhengyuan, Ganesan Vaidyanathan, Darryl McDougald, et al.. (2017). Fluorine-18 Labeling of the HER2-Targeting Single-Domain Antibody 2Rs15d Using a Residualizing Label and Preclinical Evaluation. Molecular Imaging and Biology. 19(6). 867–877. 60 indexed citations
9.
Choi, Jae‐Yeon, Ganesan Vaidyanathan, Eftychia Koumarianou, et al.. (2014). N-Succinimidyl guanidinomethyl iodobenzoate protein radiohalogenation agents: Influence of isomeric substitution on radiolabeling and target cell residualization. Nuclear Medicine and Biology. 41(10). 802–812. 17 indexed citations
10.
Pruszyński, Marek, Eftychia Koumarianou, Ganesan Vaidyanathan, et al.. (2014). Improved Tumor Targeting of Anti-HER2 Nanobody Through N-Succinimidyl 4-Guanidinomethyl-3-Iodobenzoate Radiolabeling. Journal of Nuclear Medicine. 55(4). 650–656. 79 indexed citations
11.
Pruszyński, Marek, Eftychia Koumarianou, Ganesan Vaidyanathan, et al.. (2012). Targeting breast carcinoma with radioiodinated anti-HER2 Nanobody. Nuclear Medicine and Biology. 40(1). 52–59. 91 indexed citations
12.
Vaidyanathan, Ganesan, et al.. (2010). Radioiodinated O6-Benzylguanine derivatives containing an azido function. Nuclear Medicine and Biology. 38(1). 77–92. 9 indexed citations
13.
Vaidyanathan, Ganesan, et al.. (2009). Labeling internalizing anti-epidermal growth factor receptor variant III monoclonal antibody with 177Lu: in vitro comparison of acyclic and macrocyclic ligands. Nuclear Medicine and Biology. 36(2). 117–128. 21 indexed citations
14.
Vaidyanathan, Ganesan & Michael R. Zalutsky. (2007). Synthesis of N-succinimidyl 4-guanidinomethyl-3-[*I]iodobenzoate: a radio-iodination agent for labeling internalizing proteins and peptides. Nature Protocols. 2(2). 282–286. 41 indexed citations
15.
Vaidyanathan, Ganesan, Donna J. Affleck, & Michael R. Zalutsky. (2004). No-carrier-added synthesis of a 4-methyl-substituted meta-iodobenzylguanidine analogue. Applied Radiation and Isotopes. 62(3). 435–440. 7 indexed citations
16.
Vaidyanathan, Ganesan, Donna J. Affleck, Kevin L. Alston, Philip Welsh, & Michael R. Zalutsky. (2004). Catabolism of 4-fluoro-3-iodobenzylguanidine and meta-iodobenzylguanidine by SK-N-SH neuroblastoma cells. Nuclear Medicine Communications. 25(9). 947–955. 4 indexed citations
17.
Vaidyanathan, Ganesan & Michael R. Zalutsky. (1998). Preparation of 5-[131I]Iodo- and 5-[211At]Astato-1- (2-Deoxy-2-Fluoro-β-d-Arabinofuranosyl)Uracil by a Halodestannylation Reaction. Nuclear Medicine and Biology. 25(5). 487–496. 34 indexed citations
18.
Vaidyanathan, Ganesan & Michael R. Zalutsky. (1997). Fluorine-18-labeled [Nle4,d-Phe7]-α-MSH, an α-melanocyte stimulating hormone analogue. Nuclear Medicine and Biology. 24(2). 171–178. 47 indexed citations
19.
Vaidyanathan, Ganesan, Henry S. Friedman, Stephen T. Keir, & Michael R. Zalutsky. (1996). Evaluation of meta-[211At]astatobenzylguanidine in an athymic mouse human neuroblastoma xenograft model. Nuclear Medicine and Biology. 23(6). 851–856. 31 indexed citations
20.
Vaidyanathan, Ganesan & Michael R. Zalutsky. (1994). Improved Synthesis of N-Succinimidyl 4-[18F]Fluorobenzoate and Its Application to the Labeling of a Monoclonal Antibody Fragment. Bioconjugate Chemistry. 5(4). 352–356. 71 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Reingard Senekowitsch–Schmidtke Breakdown of academic impact, for papers by Hanwen Zhang Breakdown of academic impact, for papers by Jörgen Carlsson Breakdown of academic impact, for papers by Joseph A. O’Donoghue Breakdown of academic impact, for papers by Katherine A. Vallis Breakdown of academic impact, for papers by Chang H. Paik Breakdown of academic impact, for papers by Sean Carlin Breakdown of academic impact, for papers by Carmen Wängler Breakdown of academic impact, for papers by Chien‐Hsing Chang Breakdown of academic impact, for papers by Margret Schottelius
Rankless by CCL
2026